Effects of typical antipsychotic drugs and risperidone on the quality of sleep in patients with schizophrenia: A pilot study

Journal of Psychiatry and Neuroscience

Volumn 24, Issue 4, 1999, Pages 333-

  Dursun, S M ^a,b   Patel, J K M ^a   Burke, J G ^a   Reveley, M A ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Antipsychotic agents; Chlorpromazine; Flupenthixol; Haloperidol; Risperidone; Schizophrenia; Sleep; Sleep, REM

Indexed keywords

CHLORPROMAZINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; FLUPENTIXOL; HALOPERIDOL; NEUROLEPTIC AGENT; RISPERIDONE; SEROTONIN 2A ANTAGONIST; SEROTONIN 2C ANTAGONIST;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MALE; MENTAL HOSPITAL; OUTPATIENT CARE; SCHIZOPHRENIA; SLEEP;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES; RISPERIDONE; SCHIZOPHRENIA; SLEEP;

EID: 0032705108     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Zarcone VP, Benson KL. Sleep abnormalities in schizophrenia. In: Kryger MH, Roth T, Dement W, editors. Principles and practice of sleep medicine. 2nd ed. New York: WB Saunders; 1994. p. 941-6.
2. Jus K, Bouchard M, Jus AK, Villeneuve A, Lachance R. Sleep EEG studies in untreated long-term schizophrenic patients. Arch Gen Psychiatry 1973;29:386-90.
3. Traub AC. Sleep stage deficits in chronic schizophrenia. Psychol Rep 1972;31:815-20.
4. Hiatt JF, Floyd TC, Katt PH, Feinberg I. Further evidence of abnormal NREM sleep in schizophrenia. Arch Gen Psychiatry 1985;42:797-802.
5. Caldwell DF, Domino EF. Electroencephalographic and eye movement patterns during sleep in chronic schizophrenic patients. Electroencephalogr Clin Neurophysiol 1967;22:414-20.
6. Feinberg I, Braun M, Koresko RL, Gottlieb F. Stage 4 sleep in schizophrenia. Arch Gen Psychiatry 1969;21:262-6.
7. Keshavan M, Reyonds C, Brar J, Houck P, Campbell K, Ganguli R, et al. Sleep EEG changes in schizophrenia during haloperidol treatment. [abstract] Biol Psychiatry 1989;25:181A.
8. Wetter TC, Lauer CJ, Gillich G, Pollmacher T. The electroencephalopgraphic sleep patterns in schizophrenic patients treated with clozapine or classic antipsychotic medication. J Psychiatr Res 1996;30:411-9.
9. Daniel DG, Goldberg TE, Weinberger DR, Kleinman JE, Pickar D, Lubick LJ, et al. Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study. Am J Psychiatry 1996;153:417-9.
10. Taylor SF, Tandon R, Shipley JE, Eiser AS. Effect of neuroleptic treatment on polysomnographic measures in schizophrenia. Biol Psychiatry 1991;30:904-12.
11. Kerwin RW. The new atypical antipsychotics: a lack of extrapyramidal side-effects and new routes in schizophrenia research. Br J Psychiatry 1994;164:141-8.
12. 2 antagonistic properties. J Pharmacol Exp Ther 1988;244:685-93.
13. Sharpley AL, Cowen PJ. Effect of pharmacologic treatments on the sleep of depressed patients. Biol Psychiatry 1995;37:85-98.
14. Spitzer RL, Gibbon M., Endicott J. The global assessment scale: a procedure for measuring overall severity of psychiatric disturbances. Arch Gen Psychiatry 1976;33:766-71.
15. Herman JRE, Cowen PJ, Campling GM, Hockney RA, Laver D, Sharpley AL. Effect of lofepramine on 5-HT function and sleep. J Affect Disord 1993;29:63-72.
16. Saletu B, Klosch G, Gruber G, Anderer P, Udomratn P, Frey R. First-night-effects on generalized anxiety disorder (GAD)-based insomnia: laboratory versus home sleep recordings. Sleep 1996;19:691-7.
17. Duka T, Goerke D, Frichte K. Effects of ZK 93,426, a beta-carboline benzodiazepine receptor antagonist on sleep pattern in healthy male volunteers. Psychopharmacology 1995;17:178-85.
18. Gillberg M. Kecklund G, Akerstedt T. Relations between performance and subjective ratings during a night awake. Sleep 1994;17:236-41.
19. Takahashi M, Fukuda H, Arito H. Brief naps during post-lunch rest: effects on alertness, performance, and autonomic balance. Eur J Appl Physiol 1998;78:93-8.
20. Sadeh A, Hauri PJ, Kripke DF, Lavie P, The role of actigraphy in the evaluation of sleep disorders. Sleep 1995;18:288-302.
21. Dursun SM, Andrews H, Reveley MA. Computerised continuous assessment of abnormal movements in Huntington's disease; improvement by sulpiride. Br J Clin Pharmacol 1994;37:503-4.
22. Tyron WW. Activity measurement in psychology and medicine. New York: Plenum Press; 1991, p. 23-64.
23. Naiman J, Poitras R, Engelsmann F. Effect of chlorpromazine on REM rebound in normal volunteers. Can Psychiatr Assoc J 1972;17:463-9.
24. Zarcone VP. Sleep and schizophrenia. In: Williams RL, Karacan I, Moore CA, editors. Sleep disorders. New York: Wiley; 1988. p. 165-88.
25. Dugovic C, Wauquier A, Janssen PA, Differential effects of the new antipsychotic risperidone on sleep and wakefulness in the rat. Neuropharmacology 1989;28:1431-3.
26. 2 receptors. Neuropharmacology 1994;33:467-71,
27. Jacobsen FM. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J Clin Psychiatry 1995; 56:423-9.